Animal models of major depressive disorder and the implications for drug discovery and development
- 22 February 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 14 (4) , 365-378
Abstract
Introduction: Depression is a highly debilitating psychiatric disorder that affects the global population and causes severe disabilities and suicide. Depression pathogenesis remains poorly understood, and the disorder is often treatment-resistant and recurrent, necessitating the development of novel therapies, models and concepts in this field. Areas covered: Animal models are indispensable for translational biological psychiatry, and markedly advance the study of depression. Novel approaches continuously emerge that may help untangle the disorder heterogeneity and unclear categories of disease classification systems. Some of these approaches include widening the spectrum of model species used for translational research, using a broader range of test paradigms, exploring new pathogenic pathways and biomarkers, and focusing more closely on processes beyond neural cells (e.g. glial, inflammatory and metabolic deficits). Expert opinion: Dividing the core symptoms into easily translatable, evolutionarily conserved phenotypes is an effective way to reevaluate current depression modeling. Conceptually novel approaches based on the endophenotype paradigm, cross-species trait genetics and ‘domain interplay concept’, as well as using a wider spectrum of model organisms and target systems will enhance experimental modeling of depression and antidepressant drug discovery.Keywords
Funding Information
- ETAg (MOBTT77)
- 5-100 Excellence Program (TVS2018)
- Russian Foundation for Basic Research (16-04-00851,18-34-00996)
This publication has 219 references indexed in Scilit:
- Chronic Unpredictable Stress (CUS)-Induced Anxiety and Related Mood Disorders in a Zebrafish Model: Altered Brain Proteome Profile Implicates Mitochondrial DysfunctionPLOS ONE, 2013
- Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampusPsychopharmacology, 2012
- The role of serotonin receptor subtypes in treating depression: a review of animal studiesPsychopharmacology, 2010
- Knockout of GAD65 has Major Impact on Synaptic GABA Synthesized from Astrocyte-Derived GlutamineJournal of Cerebral Blood Flow & Metabolism, 2010
- Poor replication of candidate genes for major depressive disorder using genome-wide association dataMolecular Psychiatry, 2010
- Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like BehaviorsBiological Psychiatry, 2008
- Domain interplay concept in animal models of neuropsychiatric disorders: A new strategy for high-throughput neurophenotyping researchBehavioural Brain Research, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced DepressionBiological Psychiatry, 2007
- Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depressionBrain, Behavior, and Immunity, 2007